欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (8): 1067-1075.doi: 10.12092/j.issn.1009-2501.2025.08.007

• 临床药理学 • 上一篇    下一篇

基于生理药代动力学模型的维生素D个体化给药方案研究

魏园园1, 马涛1, 唐跃洲1, 李琥波1,2, 田晓瑜1,2, 党云洁1, 周旭1   

  1. 1河北医科大学药学院,石家庄 050017,河北;
    2河北医科大学附属第二医院,石家庄 050017,河北
  • 收稿日期:2024-09-19 修回日期:2025-02-07 发布日期:2025-08-12
  • 通讯作者: 周旭,女,博士研究生,讲师,研究方向:药代动力学建模,人工智能与医工融合。E-mail: zhouxu@hebmu.edu.cn
  • 作者简介:魏园园,女,研究方向:临床药学,生理药代动力学。E-mail: 2788950421@qq.com
  • 基金资助:
    国家自然科学基金面上项目(81973251); 国家自然科学基金面上项目(81973469); 河北省自然科学基金资助项目(H2025206694); 河北省卫生健康委医学科学研究课题(20240242)

Individualized dosage study of vitamin D3 based on physiologically-based pharmacokinetic modeling

WEI Yuanyuan, MA Tao, TANG Yuezhou, LI Hubo, TIAN Xiaoyu, DANG Yunjie, ZHOU Xu   

  1. 1School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, Hebei, China;
    2The Second Hospital of Hebei Medical University, Shijiazhuang 050017, Hebei, China
  • Received:2024-09-19 Revised:2025-02-07 Published:2025-08-12

摘要: 目的:建立维生素D的成人生理药代动力学(PBPK)模型,为维生素D缺乏人群的临床合理用药提供指导。方法:查阅相关文献和数据库,获得维生素D3的理化性质和药动学参数。应用PK-Sim®软件进行维生素D成人全身PBPK模型的构建、优化和预测。以置信区间、拟合优度和倍数误差(FE)为评价指标验证模型预测性能,并根据最终的优化模型对临床常用给药方案的有效性进行评估,同时给出推荐的个体化给药方案。结果:建立的维生素D成人全身PBPK模型,拟合优度R2为0.961,接近于1,且AUC0-∞Cmax的FE值皆在0.5和2以内,这表明所建立的PBPK模型具有良好的数据预测能力。结论:成功构建了口服维生素D3的成人PBPK模型,模型对单次口服维生素D3具有良好的预测性能。单次口服维生素D3(7 500 μg和15 000 μg)是改善亚洲成年人维生素D不足/缺乏状况的安全有效的剂量方案,治疗前和治疗期间,应定期监测25羟基维生素D的水平以实现个体化治疗的最佳效果。

关键词: 维生素D3, PK-Sim®, PBPK, 药代动力学, 拟合优度, 剂量预测

Abstract: AIM: To establish a physiologically-based pharmacokinetic (PBPK) model for vitamin D in adults, aiming to provide guidance for the rational clinical use of vitamin D in individuals with vitamin D deficiency. METHODS: Relevant literature and databases were reviewed to obtain the physicochemical properties and pharmacokinetic parameters of vitamin D3. The PBPK model for adult whole-body vitamin D was constructed, optimized, and predicted using PK-Sim® software. The model's predictive performance was evaluated using confidence intervals, goodness of fit, and fold error (FE). The effectiveness of commonly used clinical dosing regimens was assessed based on the final optimized model, and personalized dosing recommendations were provided. RESULTS: The established adult whole-body PBPK model for vitamin D had a goodness of fit R² of 0.961, approaching 1, and the FE values for AUC0-∞ and Cmax were both within the range of 0.5 and 2, indicating that the constructed PBPK model possesses good data predictive capability. CONCLUSION: A successful PBPK model for oral vitamin D3 in adults has been established, showing good predictive performance for single oral doses of vitamin D3. Single oral doses of vitamin D3 (7 500 μg and 15 000 μg) are safe and effective dosing regimens for improving vitamin D insufficiency or deficiency in Asian adults. Regular monitoring of vitamin D levels before and during treatment is recommended to achieve the optimal outcomes of personalized therapy.

Key words: vitamin D3, PK-Sim®, PBPK, pharmacokinetics, goodness of fit, dose prediction

中图分类号: